These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Dopaminergic receptors: structural features and functional implications]. Nieoullon A; Amalric M Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S59-68. PubMed ID: 12690665 [TBL] [Abstract][Full Text] [Related]
4. The dopamine systems in the brain, functional classification of different dopamine receptors. Ljungberg T Acta Psychiatr Belg; 1987; 87(5):523-34. PubMed ID: 2897758 [TBL] [Abstract][Full Text] [Related]
5. Dopamine receptors and the dopamine hypothesis of schizophrenia. Seeman P Synapse; 1987; 1(2):133-52. PubMed ID: 2905529 [TBL] [Abstract][Full Text] [Related]
6. [Neurotensin, dopamine and mode of action of neuroleptics]. Tassin JP Encephale; 1989; 15(5):465-70. PubMed ID: 2574102 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic drugs and their action on different neuronal pathways. Ungerstedt U; Herrera-Marschitz M; Forster C J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478 [TBL] [Abstract][Full Text] [Related]
8. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Wood MD; Wren PB Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035 [TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology of tics. Fog R; Regeur L Rev Neurol (Paris); 1986; 142(11):856-9. PubMed ID: 2881341 [TBL] [Abstract][Full Text] [Related]
11. Central dopaminergic mechanisms in schizophrenia. Owen F; Crow TJ; Poulter M Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760 [TBL] [Abstract][Full Text] [Related]
12. Diversity of dopamine receptors: new molecular and pharmacological developments. Hartman DS; Lanau F Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762 [TBL] [Abstract][Full Text] [Related]
13. Dopaminergic mechanisms in the pathogenesis of schizophrenia. Goldstein M; Deutch AY FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713 [TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors and psychiatric drug treatment. Syvälahti EK Ann Clin Res; 1988; 20(5):340-7. PubMed ID: 2905878 [TBL] [Abstract][Full Text] [Related]
15. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168 [TBL] [Abstract][Full Text] [Related]
16. The neuropathology of schizophrenia. Bachus SE; Kleinman JE J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174 [TBL] [Abstract][Full Text] [Related]
17. Synaptic and non-synaptic striatal dopamine D2 receptors: possible implications in normal and pathological behaviour. Korf J; Loopuijt LD Acta Morphol Neerl Scand; 1988-1989; 26(2-3):177-90. PubMed ID: 2908162 [TBL] [Abstract][Full Text] [Related]
18. [A biochemical theory of schizophrenia]. Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120 [TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors and antipsychotic drug response. Sunahara RK; Seeman P; Van Tol HH; Niznik HB Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523 [TBL] [Abstract][Full Text] [Related]
20. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Goto Y; Grace AA Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]